Gregor Bieri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gregor Bieri has a total of 157 co-authors. Here are the top co-authors by number of shared publications:
- Saul A. Villeda
Department of Anatomy, University of California San Francisco, San Francisco, USA
16 shared publications - Julien Couthouis
Department of Genetics, Stanford University School of Medicine, Stanford, USA
6 shared publications - Adam B. Schroer
Department of Anatomy, University of California San Francisco, San Francisco, USA
4 shared publications - Aaron D. Gitler
Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA
3 shared publications Charles W. White
Department of Anatomy, University of California, San Francisco, San Francisco, USA
3 shared publicationsTuran Aghayev
Department of Anatomy, University of California, San Francisco, San Francisco, CA 94143, USA
3 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by Springer Nature in Research Square
Young Ovary Factors Transfer Female Cognitive Resilience to the Aged Male Brain
Women typically exhibit slower age-associated cognitive decline than men. Here, we show that young ovary-derived blood factors transfer female cognitive resilience to the aged male brain. Administration of young female-derived blood plasma elicited greater cognitive and neurogenic enhancements in aged male recipient mice compared to young male-derived plasma. Heterochronic young ovary transplantation likewise boosted cognition, neurogenesis and synaptic-related transcriptional signatures in aged males. We identify secreted frizzled-related protein 4 (SFRP4) as an ovary-enriched circulating factor in young female plasma, of which systemic elevation in aged male mice ameliorates cognitive impairments. Mechanistically, we identify bone-derived pro-youthful factor osteocalcin as a downstream peripheral mediator of SFRP4-induced cognitive benefits. Together, these findings highlight an ovary–bone–brain axis through which blood factors confer female cognitive resilience in aging.
- 3 September 2026
- Published by Springer Nature in Research Square
Open AccessYoung Ovary Factors Transfer Female Cognitive Resilience to the Aged Male Brain
Women typically exhibit slower age-associated cognitive decline than men. Here, we show that young ovary-derived blood factors transfer female cognitive resilience to the aged male brain. Administration of young female-derived blood plasma elicited greater cognitive and neurogenic enhancements in aged male recipient mice compared to young male-derived plasma. Heterochronic young ovary transplantation likewise boosted cognition, neurogenesis and synaptic-related transcriptional signatures in aged males. We identify secreted frizzled-related protein 4 (SFRP4) as an ovary-enriched circulating factor in young female plasma, of which systemic elevation in aged male mice ameliorates cognitive impairments. Mechanistically, we identify bone-derived pro-youthful factor osteocalcin as a downstream peripheral mediator of SFRP4-induced cognitive benefits. Together, these findings highlight an ovary–bone–brain axis through which blood factors confer female cognitive resilience in aging.
- Open Access
- 13 April 2026
- Published by Wiley in Advanced Science
- Vol. 13 (28) , e23511
Alzheimer's Disease Risk Factor APOE4 Exerts Dimorphic Effects on Female Bone
Individuals with Alzheimer's disease (AD) are at an increased risk of bone fracture, while osteoporosis in women is one of the earliest predictors of AD. Yet the mechanisms linking cognitive decline and skeletal deterioration remain poorly defined. Proteomic analysis of cortical bone from aged 21‐month‐old mice revealed strong enrichment of neurodegeneration‐associated proteins, including apolipoprotein E (Apoe) and amyloid precursor protein. Apoe localized specifically to osteocytes, with expression in aged female bone nearly twice that of young 4‐month‐old male bone. Because human APOE alleles confer different age‐related AD risks, we examined their roles in bone using humanized APOE2, APOE3, and APOE4 knock‐in mice and analyzed bone and hippocampus from the same animals. APOE4 produced marked sex‐specific effects on the bone transcriptome and proteome compared with APOE2 or APOE3. Strikingly, APOE4‐associated proteomic disruptions were stronger in female bone than in the hippocampus. Functionally, APOE4 caused bone fragility in females without altering cortical structure. These deficits stemmed from impaired osteocyte perilacunocanalicular remodeling. Our findings identify APOE4 as a molecular driver of early osteocyte dysfunction and reduced bone quality, disproportionately affecting females. These findings highlight osteocytes as potential targets for early diagnosis of age‐related cognitive impairment and treatment for bone fragility, in females.
- 13 April 2026
- Published by Wiley in Advanced Science
- Vol. 13 (28) , e23511
Open AccessAlzheimer's Disease Risk Factor APOE4 Exerts Dimorphic Effects on Female Bone
Individuals with Alzheimer's disease (AD) are at an increased risk of bone fracture, while osteoporosis in women is one of the earliest predictors of AD. Yet the mechanisms linking cognitive decline and skeletal deterioration remain poorly defined. Proteomic analysis of cortical bone from aged 21‐month‐old mice revealed strong enrichment of neurodegeneration‐associated proteins, including apolipoprotein E (Apoe) and amyloid precursor protein. Apoe localized specifically to osteocytes, with expression in aged female bone nearly twice that of young 4‐month‐old male bone. Because human APOE alleles confer different age‐related AD risks, we examined their roles in bone using humanized APOE2, APOE3, and APOE4 knock‐in mice and analyzed bone and hippocampus from the same animals. APOE4 produced marked sex‐specific effects on the bone transcriptome and proteome compared with APOE2 or APOE3. Strikingly, APOE4‐associated proteomic disruptions were stronger in female bone than in the hippocampus. Functionally, APOE4 caused bone fragility in females without altering cortical structure. These deficits stemmed from impaired osteocyte perilacunocanalicular remodeling. Our findings identify APOE4 as a molecular driver of early osteocyte dysfunction and reduced bone quality, disproportionately affecting females. These findings highlight osteocytes as potential targets for early diagnosis of age‐related cognitive impairment and treatment for bone fragility, in females.
- Top Cited PapersOpen Access
Liver exerkine reverses aging- and Alzheimer’s-related memory loss via vasculature
Top Cited PapersOpen AccessLiver exerkine reverses aging- and Alzheimer’s-related memory loss via vasculature
- Top Cited PapersOpen Access
- 9 January 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (2)
Systematic identification of single transcription factor perturbations that drive cellular and tissue rejuvenation
Cellular rejuvenation through transcriptional reprogramming is an exciting approach to counter aging. Using a fibroblast-based model of human cell aging and Perturb-seq screening, we developed a systematic approach to identify single transcription factor (TF) perturbations that promote rejuvenation without dedifferentiation. Overexpressing E2F3 or EZH2, and repressing STAT3 or ZFX, reversed cellular hallmarks of aging—increasing proliferation, proteostasis, and mitochondrial activity, while decreasing senescence. EZH2 overexpression in vivo rejuvenated livers in aged mice, reversing aging-associated gene expression profiles, decreasing steatosis and fibrosis, and improving glucose tolerance. Mechanistically, single TF perturbations led to convergent downstream transcriptional programs conserved in different aging and rejuvenation models. These results suggest a shared set of molecular requirements for cellular and tissue rejuvenation across species.
- 9 January 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (2)
Top Cited PapersOpen AccessSystematic identification of single transcription factor perturbations that drive cellular and tissue rejuvenation
Cellular rejuvenation through transcriptional reprogramming is an exciting approach to counter aging. Using a fibroblast-based model of human cell aging and Perturb-seq screening, we developed a systematic approach to identify single transcription factor (TF) perturbations that promote rejuvenation without dedifferentiation. Overexpressing E2F3 or EZH2, and repressing STAT3 or ZFX, reversed cellular hallmarks of aging—increasing proliferation, proteostasis, and mitochondrial activity, while decreasing senescence. EZH2 overexpression in vivo rejuvenated livers in aged mice, reversing aging-associated gene expression profiles, decreasing steatosis and fibrosis, and improving glucose tolerance. Mechanistically, single TF perturbations led to convergent downstream transcriptional programs conserved in different aging and rejuvenation models. These results suggest a shared set of molecular requirements for cellular and tissue rejuvenation across species.
- Open Access
Alzheimer’s disease risk factor APOE4 exerts dimorphic effects on female bone
Individuals diagnosed with Alzheimer’s disease (AD) are at an increased risk of bone fractures. Conversely, a diagnosis of osteoporosis in women is the earliest known predictor for AD. However, mechanisms responsible for the coupled decline in cognitive and skeletal health remain unclear. Proteomic analysis of cortical bone from aged mice revealed neurological disease-associated proteins that are highly enriched in aged mouse bones, including apolipoprotein E (Apoe) and amyloid precursor protein. Further, Apoe localized specifically to bone-embedded osteocytes with expression twice as high in aged female bone as in young or male counterparts. In humans, APOE allele variants carry differing AD risk with age. To investigate APOE allelic roles in bone, we utilized a humanized APOE knock-in mouse model that expresses either the protective APOE2, the neutral APOE3, or the AD risk factor APOE4, and analyzed bone and hippocampus from the same mice. APOE4 exerted strong sex-specific effects on the bone transcriptome and proteome, relative to APOE2 or APOE3. Interestingly, the APOE4-associated perturbation in the female bone proteome was more pronounced than the corresponding alterations observed in the hippocampus. APOE4 protein causes bone fragility in females, but not males, even without changes in cortical bone structure. These bone quality deficits arose from suppression of osteocyte perilacunocanalicular remodeling. We find that APOE4 is a new molecular culprit capable of disrupting osteocyte maintenance of bone quality as early as midlife in a manner that disproportionately affects females. These findings highlight osteocytes as potential targets for early diagnosis of age-related cognitive impairment, and treatment for bone fragility, in females.
Open AccessAlzheimer’s disease risk factor APOE4 exerts dimorphic effects on female bone
Individuals diagnosed with Alzheimer’s disease (AD) are at an increased risk of bone fractures. Conversely, a diagnosis of osteoporosis in women is the earliest known predictor for AD. However, mechanisms responsible for the coupled decline in cognitive and skeletal health remain unclear. Proteomic analysis of cortical bone from aged mice revealed neurological disease-associated proteins that are highly enriched in aged mouse bones, including apolipoprotein E (Apoe) and amyloid precursor protein. Further, Apoe localized specifically to bone-embedded osteocytes with expression twice as high in aged female bone as in young or male counterparts. In humans, APOE allele variants carry differing AD risk with age. To investigate APOE allelic roles in bone, we utilized a humanized APOE knock-in mouse model that expresses either the protective APOE2, the neutral APOE3, or the AD risk factor APOE4, and analyzed bone and hippocampus from the same mice. APOE4 exerted strong sex-specific effects on the bone transcriptome and proteome, relative to APOE2 or APOE3. Interestingly, the APOE4-associated perturbation in the female bone proteome was more pronounced than the corresponding alterations observed in the hippocampus. APOE4 protein causes bone fragility in females, but not males, even without changes in cortical bone structure. These bone quality deficits arose from suppression of osteocyte perilacunocanalicular remodeling. We find that APOE4 is a new molecular culprit capable of disrupting osteocyte maintenance of bone quality as early as midlife in a manner that disproportionately affects females. These findings highlight osteocytes as potential targets for early diagnosis of age-related cognitive impairment, and treatment for bone fragility, in females.
- Open Access
- 19 August 2025
- Published by Springer Nature in Nature Aging
- Vol. 5 (10) , 1957-1969
Targeting iron-associated protein Ftl1 in the brain of old mice improves age-related cognitive impairment
Understanding cellular and molecular drivers of age-related cognitive decline is necessary to identify targets to restore cognition at old age. Here we identify ferritin light chain 1 (FTL1), an iron-associated protein, as a pro-aging neuronal factor that impairs cognition. Using transcriptomic and mass spectrometry approaches, we detect an increase in neuronal FTL1 in the hippocampus of aged mice, the levels of which correlate with cognitive decline. Mimicking an age-related increase in neuronal FTL1 in young mice alters labile iron oxidation states and promotes synaptic and cognitive features of hippocampal aging. Targeting neuronal FTL1 in the hippocampi of aged mice improves synaptic-related molecular changes and cognitive impairments. Using neuronal nuclei RNA sequencing, we detect changes in metabolic processes, such as ATP synthesis, and boosting these metabolic functions through NADH supplementation mitigated pro-aging effects of neuronal FTL1 on cognition. Our data identify neuronal FTL1 as a key molecular mediator of cognitive rejuvenation.
- 19 August 2025
- Published by Springer Nature in Nature Aging
- Vol. 5 (10) , 1957-1969
Open AccessTargeting iron-associated protein Ftl1 in the brain of old mice improves age-related cognitive impairment
Understanding cellular and molecular drivers of age-related cognitive decline is necessary to identify targets to restore cognition at old age. Here we identify ferritin light chain 1 (FTL1), an iron-associated protein, as a pro-aging neuronal factor that impairs cognition. Using transcriptomic and mass spectrometry approaches, we detect an increase in neuronal FTL1 in the hippocampus of aged mice, the levels of which correlate with cognitive decline. Mimicking an age-related increase in neuronal FTL1 in young mice alters labile iron oxidation states and promotes synaptic and cognitive features of hippocampal aging. Targeting neuronal FTL1 in the hippocampi of aged mice improves synaptic-related molecular changes and cognitive impairments. Using neuronal nuclei RNA sequencing, we detect changes in metabolic processes, such as ATP synthesis, and boosting these metabolic functions through NADH supplementation mitigated pro-aging effects of neuronal FTL1 on cognition. Our data identify neuronal FTL1 as a key molecular mediator of cognitive rejuvenation.
- Open Access
- 16 August 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-20
Platelet-derived exerkine CXCL4/platelet factor 4 rejuvenates hippocampal neurogenesis and restores cognitive function in aged mice
The beneficial effects of physical activity on brain ageing are well recognised, with exerkines, factors that are secreted into the circulation in response to exercise, emerging as likely mediators of this response. However, the source and identity of these exerkines remain unclear. Here we provide evidence that an anti-geronic exerkine is secreted by platelets. We show that platelets are activated by exercise and are required for the exercise-induced increase in hippocampal precursor cell proliferation in aged mice. We also demonstrate that increasing the systemic levels of the platelet-derived exerkine CXCL4/platelet factor 4 (PF4) ameliorates age-related regenerative and cognitive impairments in a hippocampal neurogenesis-dependent manner. Together these findings highlight the role of platelets in mediating the rejuvenating effects of exercise during physiological brain ageing.
- 16 August 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-20
Open AccessPlatelet-derived exerkine CXCL4/platelet factor 4 rejuvenates hippocampal neurogenesis and restores cognitive function in aged mice
The beneficial effects of physical activity on brain ageing are well recognised, with exerkines, factors that are secreted into the circulation in response to exercise, emerging as likely mediators of this response. However, the source and identity of these exerkines remain unclear. Here we provide evidence that an anti-geronic exerkine is secreted by platelets. We show that platelets are activated by exercise and are required for the exercise-induced increase in hippocampal precursor cell proliferation in aged mice. We also demonstrate that increasing the systemic levels of the platelet-derived exerkine CXCL4/platelet factor 4 (PF4) ameliorates age-related regenerative and cognitive impairments in a hippocampal neurogenesis-dependent manner. Together these findings highlight the role of platelets in mediating the rejuvenating effects of exercise during physiological brain ageing.
- Top Cited PapersOpen Access
- 16 August 2023
- Published by Springer Nature in Nature
- Vol. 620 (7976) , 1071-1079
Platelet factors attenuate inflammation and rescue cognition in ageing
Identifying therapeutics to delay, and potentially reverse, age-related cognitive decline is critical in light of the increased incidence of dementia-related disorders forecasted in the growing older population1. Here we show that platelet factors transfer the benefits of young blood to the ageing brain. Systemic exposure of aged male mice to a fraction of blood plasma from young mice containing platelets decreased neuroinflammation in the hippocampus at the transcriptional and cellular level and ameliorated hippocampal-dependent cognitive impairments. Circulating levels of the platelet-derived chemokine platelet factor 4 (PF4) (also known as CXCL4) were elevated in blood plasma preparations of young mice and humans relative to older individuals. Systemic administration of exogenous PF4 attenuated age-related hippocampal neuroinflammation, elicited synaptic-plasticity-related molecular changes and improved cognition in aged mice. We implicate decreased levels of circulating pro-ageing immune factors and restoration of the ageing peripheral immune system in the beneficial effects of systemic PF4 on the aged brain. Mechanistically, we identified CXCR3 as a chemokine receptor that, in part, mediates the cellular, molecular and cognitive benefits of systemic PF4 on the aged brain. Together, our data identify platelet-derived factors as potential therapeutic targets to abate inflammation and rescue cognition in old age.
- 16 August 2023
- Published by Springer Nature in Nature
- Vol. 620 (7976) , 1071-1079
Top Cited PapersOpen AccessPlatelet factors attenuate inflammation and rescue cognition in ageing
Identifying therapeutics to delay, and potentially reverse, age-related cognitive decline is critical in light of the increased incidence of dementia-related disorders forecasted in the growing older population1. Here we show that platelet factors transfer the benefits of young blood to the ageing brain. Systemic exposure of aged male mice to a fraction of blood plasma from young mice containing platelets decreased neuroinflammation in the hippocampus at the transcriptional and cellular level and ameliorated hippocampal-dependent cognitive impairments. Circulating levels of the platelet-derived chemokine platelet factor 4 (PF4) (also known as CXCL4) were elevated in blood plasma preparations of young mice and humans relative to older individuals. Systemic administration of exogenous PF4 attenuated age-related hippocampal neuroinflammation, elicited synaptic-plasticity-related molecular changes and improved cognition in aged mice. We implicate decreased levels of circulating pro-ageing immune factors and restoration of the ageing peripheral immune system in the beneficial effects of systemic PF4 on the aged brain. Mechanistically, we identified CXCR3 as a chemokine receptor that, in part, mediates the cellular, molecular and cognitive benefits of systemic PF4 on the aged brain. Together, our data identify platelet-derived factors as potential therapeutic targets to abate inflammation and rescue cognition in old age.
- Open Access
- 21 July 2023
- Published by Elsevier in The Journal of Pain
- Vol. 25 (1) , 53-63
Pain and Itch Processing in Aged Mice
- 21 July 2023
- Published by Elsevier in The Journal of Pain
- Vol. 25 (1) , 53-63
Open AccessPain and Itch Processing in Aged Mice
- Open Access
Neuronal Activation of the Gαq Protein EGL-30/GNAQ Late in Life Rejuvenates Cognition Across Species
Cognitive decline is perhaps the most devastating aging loss. EGL-30/GNAQ and Gαq signaling pathways are highly conserved between C. elegans and mammals. We find that activation of EGL-30 in aged worms at least triples memory span, and we wondered if this highly conserved pathway could also improve memory in very old mice. Murine Gnaq is enriched in hippocampal excitatory neurons and declines with age. Furthermore, GNAQ gain-of-function significantly improved memory in aged mice: GNAQ ( gf ) in hippocampal neurons of 24-month-old mice rescued age-related impairments in health metrics and long-term memory. Single-nucleus RNAseq revealed gene expression changes related to synaptic function, axon guidance, and learning and memory pathways. Several worm orthologs of mouse genes upregulated by GNAQ(gf) overexpression are required for EGL-30(gf)-dependent memory improvement. These results demonstrate that the molecular and genetic pathways between C. elegans and mammals are highly conserved, as activation of EGL-30/GNAQ, a pathway first identified in worms, rejuvenates cognitive function in two-year old mice (the equivalent of 70-80 yo humans). To our knowledge, this is the oldest age an intervention has successfully improved age-related cognitive decline. One-Sentence Summary: Neuronal activation of the Gαq protein EGL-30/GNAQ restores long-term memory at old age in worms and mice.
Open AccessNeuronal Activation of the Gαq Protein EGL-30/GNAQ Late in Life Rejuvenates Cognition Across Species
Cognitive decline is perhaps the most devastating aging loss. EGL-30/GNAQ and Gαq signaling pathways are highly conserved between C. elegans and mammals. We find that activation of EGL-30 in aged worms at least triples memory span, and we wondered if this highly conserved pathway could also improve memory in very old mice. Murine Gnaq is enriched in hippocampal excitatory neurons and declines with age. Furthermore, GNAQ gain-of-function significantly improved memory in aged mice: GNAQ ( gf ) in hippocampal neurons of 24-month-old mice rescued age-related impairments in health metrics and long-term memory. Single-nucleus RNAseq revealed gene expression changes related to synaptic function, axon guidance, and learning and memory pathways. Several worm orthologs of mouse genes upregulated by GNAQ(gf) overexpression are required for EGL-30(gf)-dependent memory improvement. These results demonstrate that the molecular and genetic pathways between C. elegans and mammals are highly conserved, as activation of EGL-30/GNAQ, a pathway first identified in worms, rejuvenates cognitive function in two-year old mice (the equivalent of 70-80 yo humans). To our knowledge, this is the oldest age an intervention has successfully improved age-related cognitive decline. One-Sentence Summary: Neuronal activation of the Gαq protein EGL-30/GNAQ restores long-term memory at old age in worms and mice.